Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.66 USD | -3.34% | +2.47% | -25.06% |
May. 20 | HC Wainwright Starts Coverage on Prime Medicine With Buy Rating, $10 Price Target | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.06% | 797M | |
+19.08% | 125B | |
+14.42% | 108B | |
-4.84% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.32% | 16.5B | |
+2.65% | 13.39B | |
+29.10% | 11.1B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating